CORRECTING and REPLACING - Exela Technologies, Inc. Reports First Quarter 2018 Results; Pro forma Revenue growth of 8.7%; Net Loss of $24 million; Pro forma Adjusted EBITDA Growth of 10.9%; Increases 2018 Revenue and Adjusted EBITDA Guidance
CORRECTING and REPLACING - Exela Technologies, Inc. Reports First Quarter 2018 Results; Pro forma Revenue growth of 8.7%; Net Loss of $24 million; Pro forma Adjusted EBITDA Growth of 10.9%; Increases 2018 Revenue and Adjusted EBITDA Guidance

In Consolidated Statements of Income, “Net Loss Per Share” for the three months ended March 31, 2018 and the three months ended March 31, 2017 should read: (0.16) and (0.24), respectively, instead of (1.64) and (2.45), respectively.

The corrected release reads:

First Quarter 2018 Highlights:

Revenue of $393.2 million, representing pro forma year-over-year growth of 8.7%

Net loss of $24.0 million, a year-over-year improvement from a pro forma net loss of $25.4 million

Adjusted EBITDA of $69.6 million, representing pro forma year-over-year growth of 10.9%

Adjusted EBITDA margin of 17.7%, representing pro forma year-over year improvement of 40 basis points

Achieved $14.8 million of savings during the first quarter of 2018 and reiterate anticipated savings of $40 million to $45 million during 2018

Operating Income of $14.7 million, flat on a year-over-year basis

EBITDA of $56.1 million, an increase of 30% year-over-year

Previously announced share buyback program remains in effect and as of the date of this release, total shares purchased equal 186,205

Increases 2018 revenue and adjusted EBITDA guidance

Irving, Texas, May 11, 2018 (GLOBE NEWSWIRE) -- Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ:XELA), one of the largest global providers of platforms for Business Process Automation (“BPA”), announced today its financial results for the first quarter ended March 31, 2018.

“We are beginning to see the benefits provided through the successful execution of our strategy. I am pleased to report our first quarter results, highlighted by pro forma revenue growth of 8.7% and pro forma adjusted EBITDA growth of 10.9%. Based on our strong first quarter results, we are increasing our outlook for both revenue and adjusted EBITDA,” said Ronald Cogburn, Chief Executive Officer.

Cogburn continued, “The mission to extend Exela’s global leadership position in business process automation continues. We have significant white space opportunity to harvest, and we are expanding our customer engagements. For example, we are opening Exela innovation centers in key Exela markets. At these centers, we showcase our full suite of solutions and collaborate with our customers to solve problems and launch new services. Early signs are positive, with over 24 pilot programs at work to share the breadth and depth of Exela solutions with our customers. We continue to invest in people and technology to further build upon increased customer awareness."

Financial information contained in this press release is presented pro forma for the business combination of Quinpario Acquisition Corp. 2, SourceHOV Holdings, Inc. (“SourceHOV”) and Novitex Holdings, Inc. (“Novitex”), which closed on July 12, 2017. The primary pro forma adjustment is to include the results of Novitex for the period January 1, 2017 to July 12, 2017. For more information, please refer to the reconciliation of reported to pro forma financial results contained in the Schedules of this release.

First Quarter Ended March 31, 2018 Financial Highlights

(Note: all Q1 2017 numbers, unless otherwise stated, are presented on a pro forma basis.)

  • Revenue: Revenue of $393.1 million, an increase of 8.7% from $361.9 million in the first quarter of 2017, and an increase of 1.8% from $386.3 million in the fourth quarter of 2017. Please refer to the pro forma revenue reconciliation contained in this press release for the first quarter of 2017. ITPS revenue was $311.9 million, an increase of 11.6% year-over-year, driven primarily by increased volumes and expansion of services within existing customers. HS revenue was in-line with expectations at $58.6 million, a slight decrease of 0.8%. LLPS revenue was in-line with expectations at $22.6 million, a decline of 3.4%.
  • 6 customers over $25 million in annual revenue and approximately 200 customers with more than $1 million annual revenue.
  • Revenue per full-time employee increased sequentially to $69 thousand from $66 thousand.
  • Total contract value won as of March 31, 2018, on a trailing-twelve-month basis, totaled $1.525 billion
  • Renewal rate on strategic accounts greater than 95%.
  • Net Loss for the first quarter of 2018 totaled $24.0 million, an improvement when compared to a pro forma net loss of $25.4 million in the first quarter of 2017.
  • Adjusted EBITDA: Adjusted EBITDA was $69.6 million, an increase of 10.9% when compared to pro forma Adjusted EBITDA of $62.7 million in the first quarter of 2017. The increase in first quarter 2018 Adjusted EBITDA was primarily driven by revenue growth and the impact of the Company’s cost savings initiatives, partially offset by ramp-up costs associated with new ITPS client contracts, investments in the Company’s revenue growth initiatives, and higher public company costs.
  • Adjusted EBITDA Margin: Adjusted EBITDA margin was 17.7%, representing an improvement of 40 basis points when compared to an Adjusted EBITDA margin of 17.3% in the first quarter of 2017. The improvement in Adjusted EBITDA margin was primarily driven by revenue growth and the impact of the Company’s cost savings initiatives, partially offset by ramp-up costs associated with new ITPS client contracts, investments in the Company’s revenue growth initiatives, and higher public company costs.
  • Capital Expenditures: 2.2% of Q1 2018 revenue compared to 3.1% in Q1 2017.
  • Share buyback: As of the date of this release, total shares repurchased under the Company’s share buyback program totaled 186,205. Company anticipates continuing to be opportunistic in purchasing of shares under the current buyback program; particularly given the Company’s view that shares are undervalued at current levels.

 

Balance Sheet and Liquidity

  • Balance Sheet and Liquidity: At March 31, 2018, Exela’s total liquidity was $117 million, measured as $26.9 million of cash and cash equivalents, $10.4 million of restricted cash with no legal restriction, and $79.4 million of available revolving credit facility ($100 million of revolving credit facility less $20.6 million of letters of credit). Total net debt was $1.368 billion (measured as total consolidated debt of $1.406 billion less cash balances not legally restricted of $37.3 million). During the first quarter, the Company made a cumulative $26.5 million investment in initiatives intended to drive growth including: business optimization expenses and working capital growth. Investments in the aforementioned growth initiatives resulted in a sequential decline in liquidity.

 

Outlook

2018

  • Company increases 2018 guidance for revenue and adjusted EBITDA.
  • Revenue range increased to $1.55 billion to $1.58 billion from $1.51 billion to $1.54 billion previously. Increased range drives pro forma growth of 6.5% to 8.5%, up from pro forma growth of 4% to 6% previously.
  • Adjusted EBITDA range increased to $295 million to $310 million from $290 million to $310 million previously. Increased range drives pro forma year-over-year growth of 20% to 26%; and expansion of adjusted EBITDA margins in the range of 220 basis points to 320 basis points.
  • Further Adjusted EBITDA guidance – in the range of $330 million to $355 million or a margin of 21% to 22%.
  • Guidance includes delivering $40 million to $45 million in savings during 2018 with remaining to be achieved beyond 2018.

Long-term

  • Revenue growth in the range of 3% to 4%
  • Adjusted EBITDA margin guidance in the range of 22% to 23%
  • Adjusted Free Cash Flow conversion in the range of 87% to 89%

Guidance is based on constant-currency.

Note on Outlook: The company has not forecasted net income/(loss) on a forward-looking basis due to the high variability and difficulty in predicting certain items that affect GAAP net income/(loss) including income tax expense, and stock-based compensation expense. Adjusted EBITDA should not be used to predict net income/(loss) as the difference between the two measures is variable.

The above outlook is based on first quarter 2018 results. Reconciliations are available in the attached tables.

Earnings Conference Call and Audio Webcast

Exela will host a conference call to discuss its first quarter 2018 financial results today at 5:00 p.m. EDT. To access this call, dial 800-860-2442 or +412-858-4600. A replay of this conference call will be available through May 17, 2018 at 877-344-7529 or +412-317-0088 (international). The replay passcode is 10119270. A live webcast of this conference call will be available on the “Investors” page of the Company’s website (www.exelatech.com). A supplemental slide presentation that accompanies this call and webcast can be found on the investor relations website (http://investors.exelatech.com) and will remain available after the call. Exela has also posted additional historical financial information regarding SourceHOV Holdings, Inc. and Novitex Holdings, Inc. on a combined basis to its investor relations website, (http://investors.exelatech.com).

About Exela: Embracing complexity. Delivering simplicitySM

Exela is a global business process automation leader combining industry-specific and industry-agnostic enterprise software and solutions with decades of experience. Our BPA suite of solutions are deployed across banking, healthcare, insurance and other industries to support mission-critical environments. Exela is a leader in workflow automation, attended and unattended cognitive automation, digital mailrooms, print communications, and payment processing with deployments across the globe.

Exela partners with customers to improve user experience and quality through operational efficiency. Exela serves over 3,500 customers across more than 50 countries, through a secure, cloud-enabled global delivery model. We are 22,000 employees strong at nearly 1,100 onsite customer facilities and more than 150 delivery centers located throughout the Americas, Europe and Asia. Our customer list includes 60% of the Fortune® 100, along with many of the world’s largest retail chains, banks, law firms, healthcare insurance payers and providers and telecom companies. Find out more at www.exelatech.com

About Non-GAAP Financial Measures

This earnings release presents certain non-GAAP financial measures including EBITDA, Adjusted EBITDA, Further Adjusted EBITDA, Further Adjusted Free Cash Flow, each of which is a financial measure that is not prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). We believe that the presentation of these non-GAAP financial measures will provide useful information to investors in assessing our financial performance, results of operations and liquidity. We believe these non-GAAP measures allow investors to better understand the trends in our business and to better understand and compare our results. Our board of directors and management use EBITDA, Adjusted EBITDA, Further Adjusted EBITDA, and Further Adjusted Free Cash Flow to assess our financial performance, because it allows them to compare our operating performance on a consistent basis across periods by removing the effects of our capital structure (such as varying levels of debt and interest expense, as well as transaction costs resulting from the business combination and other such capital markets based activities. Adjusted EBITDA and Further Adjusted EBITDA also seek to remove the effects of integration and related costs to achieve the savings, any expected reduction in operating expenses due to the business combination, asset base (such as depreciation and amortization) and other similar non-routine items outside the control of our management team. The Company does not consider these non-GAAP measures in isolation or as an alternative to liquidity or financial measures determined in accordance with GAAP. A limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company’s financial statements. In addition, they are subject to inherent limitations as they reflect the exercise of judgments by management about which expenses and income are excluded or included in determining these non-GAAP financial measures and therefore the basis of presentation for these measures may not be comparable to similarly-titled measures used by other companies. These non-GAAP financial measures are not required to be uniformly applied, are not audited and should not be considered in isolation or as substitutes for results prepared in accordance with GAAP. Net loss is the GAAP measure most directly comparable our non-GAAP measures. For reconciliation of the comparable GAAP measures to these non-GAAP financial measures, see the schedules to this release. Optimization & restructuring expenses and merger adjustments are primarily related to the implementation of strategic actions and initiatives related to the business combination completed on July 12, 2017. All of these costs are variable and dependent upon the nature of the actions being implemented and can vary significantly driven by business needs. Accordingly, due to that significant variability, we exclude these charges since we do not believe they truly reflect our past, current or future operating performance.

Forward-Looking Statements

Certain statements included in this press release are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “may”, “should”, “would”, “plan”, “intend”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, “seem”, “seek”, “continue”, “future”, “will”, “expect”, “outlook” or other similar words, phrases or expressions. These forward-looking statements include statements regarding our industry, future events, the estimated or anticipated future results and benefits of the recently consummated transaction between Exela Technologies, Inc., SourceHOV Holdings, Inc., and Novitex Holdings, Inc. (including the related transactions, the “Business Combination”), future opportunities for the combined company, and other statements that are not historical facts. These statements are based on the current expectations of Exela management and are not predictions of actual performance. These statements are subject to a number of risks and uncertainties regarding Exela’s businesses, and actual results may differ materially. These risks and uncertainties include, but are not limited to, changes in the business environment in which Exela operates and general financial, economic, regulatory and political conditions affecting the industries in which Exela operates; changes in taxes, governmental laws, and regulations; competitive product and pricing activity; failure to realize the anticipated benefits of the Business Combination, including as a result of a delay or difficulty in integrating the businesses of SourceHOV and Novitex or the inability to realize the expected amount and timing of cost savings and operating synergies of the Business Combination; and those factors discussed under the heading “Risk Factors” in Exela’s 10K dated March 16, 2018 filed with the Securities and Exchange Commission (“SEC”). In addition, forward-looking statements provide Exela’s expectations, plans or forecasts of future events and views as of the date of this communication. Exela anticipates that subsequent events and developments will cause Exela’s assessments to change. These forward-looking statements should not be relied upon as representing Exela’s assessments as of any date subsequent to the date of this presentation.

Exela Technologies

Condensed Consolidated Balance Sheet (Unaudited)

       
  March 31, 2018   December 31, 2017
  (Unaudited)        
Assets      
Current assets      
Cash and cash equivalents $ 26,882     $ 39,000  
Restricted cash   12,549       42,489  
Accounts receivable, net of allowance for doubtful accounts of $4,077 and $3,725, respectively   238,680       229,704  
Inventories, net   13,519       11,922  
Prepaid expenses and other current assets   27,456       24,596  
Current deferred tax asset   64       -  
Total current assets     319,150         347,711  
Property, plant and equipment, net   132,870       132,908  
Goodwill   747,325       747,325  
Intangible assets, net   438,929       464,984  
Deferred income tax assets   9,171       9,019  
Other noncurrent assets   18,490       12,891  
Total assets $  1,665,935     $    1,714,838  
Liabilities and Stockholders’ Deficit      
Liabilities      
Current Liabilities      
Accounts payable $ 77,194     $ 81,263  
Related party payables   14,172       14,445  
Income tax payable   6,967       3,612  
Accrued liabilities   31,805       49,383  
Accrued compensation and benefits   49,738       46,925  
Accrued Interest   23,795       55,102  
Customer deposits   36,542       31,656  
Deferred revenue   15,933       12,709  
Obligation for claim payment   56,554       42,489  
Current portion of capital lease obligations   14,785       15,611  
Current portion of long-term debt   21,170       20,565  
Total current liabilities     348,655         373,760  
Long-term debt, net of current maturities   1,277,029       1,276,094  
Capital lease obligations, net of current maturities   26,474       25,958  
Pension liability   26,081       25,496  
Deferred income tax liabilities   5,478       5,362  
Long-term income tax liability   3,470       3,470  
Other long-term liabilities   13,879       14,704  
Total liabilities   1,701,066       1,724,844  
Commitments and Contingencies (Note 9)      
Stockholders' deficit      
Common stock, par value of $0.0001 per share; 1,600,000,000 shares authorized; 152,565,218 shares issued and 152,515,918 outstanding at March 31, 2018 and 150,578,451 shares issued and 150,529,151 outstanding at December 31, 2017   15       15  
Preferred stock, par value of $0.0001 per shares; 20,000,000 shares authorized; 4,569,233 shares issued and outstanding at March 31, 2018 and 6,194,233 shares issued and outstanding at December 31, 2017   1       1  
Additional paid in capital   482,018       482,018  
Less:common stock held in treasury, at cost; 49,300 shares at March 31, 2018 and 49,300 shares at December 31, 2017   (249 )     (249 )
Equity based compensation   35,044       34,085  
Accumulated deficit   (540,041 )     (514,628 )
Accumulated other comprehensive loss:      
Foreign currency translation adjustment   (462 )     (194 )
Unrealized pension actuarial losses, net of tax   (11,457 )     (11,054 )
Total accumulated other comprehensive loss   (11,919 )     (11,248 )
Total stockholders' deficit     (35,131 )       (10,006 )
Total liabilities and stockholders' deficit $  1,665,935     $    1,714,838  
           

 

     
Exela Technologies, Inc. 
Condensed Consolidated Statements of Income (Loss) (Unaudited)
             
             
Financial Statement Workbook            
March 31, 2018            
(in thousands)            
    Three Months ended March 31,
      2018     2017
Revenue   $ 393,167   $ 218,260
Cost of revenue (exclusive of depreciation and amortization)     293,792     143,708
Selling, general and administrative expenses     45,595     35,581
Depreciation and amortization     38,019     21,320
Related party expense     1,105     2,385
Operating income (loss)     14,656     15,266
Other expense (income), net:            
Interest expense, net     38,017     26,219
Sundry expense (income), net     (64)     2,724
Other income, net     (3,328)     -
Net loss before income taxes     (19,969)     (13,677)
Income tax (expense) benefit     (4,025)     (2,004)
Net loss     (23,994)     (15,681)
Cumulative dividends for Series A Preferred Stock     (914)     -
Net loss attributable to common stockholders   $ (24,908)   $ (15,681)
Net loss per share - basic and diluted     (0.16)     (.24)
 

Exela Technologies 

Condensed Consolidated Statements of Cash Flows (Unaudited)

   
  Three Months ended March 31,
  2018   2017
Cash flows from operating activities      
Net loss $ (23,994 )   $ (15,681 )
Adjustments to reconcile net loss      
Depreciation and amortization   38,019       21,320  
Original issue discount and debt issuance cost amortization   2,595       3,474  
Provision (recovery) for doubtful accounts   481       79  
Deferred income tax benefit   835       627  
Share-based compensation expense   959       310  
Foreign currency remeasurement   (323 )     687  
Gain on sale of Meridian   -       (251 )
Loss on sale of property, plant and equipment   253       272  
Fair value adjustment for interest rate swap   (3,328 )     -  
Change in operating assets and liabilities, net of effect from acquisitions      
Accounts receivable   (10,876 )     (1,086 )
Prepaid expenses and other assets   (5,567 )     (3,720 )
Accounts payable and accrued liabilities   (18,864 )     1,928  
Related party payables   (273 )     (3,690 )
Net cash provided by (used in) operating activities   (20,083 )     4,269  
       
Cash flows from investing activities      
Purchases of property, plant and equipment   (5,957 )     (2,045 )
Additions to internally developed software   (1,092 )     (2,528 )
Additions to outsourcing contract costs   (1,596 )     (3,989 )
Proceeds from sale of Meridian   -       4,381  
Proceeds from sale of property, plant, and equipment   2       -  
Net cash used in investing activities   (8,643 )     (4,181 )
       
Cash flows from financing activities      
Change in bank overdraft   -       (210 )
Proceeds from financing obligations   1,863       3,008  
Contribution from shareholders   -       20,538  
Cash paid for equity issue costs   (7,500 )     -  
Borrowings from revolver and swing-line loan   25,000       38,500  
Repayments from revolver and swing line loan   (25,000 )     (38,500 )
Principal payments on long-term obligations   (7,750 )     (15,786 )
Net cash provided by (used in) financing activities   (13,387 )     7,550  
Effect of exchange rates on cash   55       (44 )
Net increase (decrease) in cash and cash equivalents    (42,058 )     7,594  
Cash, restricted cash, and cash equivalents      
Beginning of period   81,489       34,253  
End of period $ 39,431     $ 41,847  
       
Supplemental cash flow data:      
Income tax payments, net of refunds received $ 1,053     $ (12 )
Interest paid   66,192       30,844  
Noncash investing and financing activities:      
Assets acquired through capital lease arrangements   4,432       68  
Accrued capital expenditures   1,101       98  
       

Exela Technologies 

Schedule 1: Pro Forma First Quarter 2017 vs. First Quarter 2018 Financial Performance

             
             
($ in millions)   Q1 2018   Pro forma

Q1 2017
  % Change
Revenue            
Information and Transaction Processing Solutions   $311.9   $279.4   11.6%
Healthcare Solutions   58.6   59.1   -0.8%
Legal and Loss Prevention Services   22.6   23.4   -3.4%
Total Revenue   $393.2   $361.9   8.7%
             
Cost of revenue (exclusive of depreciation and amortization)   293.8   261.9    
Selling, general and administrative expenses (Including related party)   46.7   54.3    
Depreciation and amortization   38.0   31.0    
Impairment of goodwill and other intangible assets    0.0   0.0    
Operating income (loss)   14.7   14.7    
             
Interest expense, net   38.0   38.3    
Loss / (Gain) on extinguishment of debt   0.0   0.0    
Sundry expense (income) & Other income, net   (3.4)   2.7    
Net loss before income taxes   (20.0)   (26.4)    
Income tax expense / (benefit)   4.0    (1.0)    
Net loss   (24.0)   (25.4)    
             
Depreciation and amortization   38.0   31.0    
Interest expense, net   38.0   38.3    
Income tax expense / (benefit)   4.0   (1.0)    
EBITDA   56.1   43.0    
Transaction related costs   1.1   10.0    
Optimization and restructuring expenses   14.5   5.9    
Non-cash charges / (gains), oversight & management fees   (2.1)   3.8    
Adjusted EBITDA   $69.6   $62.7   10.9%
    17.7%   17.3%    
             

Exela Technologies 

Schedule 2: Adjusted EBITDA Reconciliation – Pro Forma First Quarter 2017

             
($ in millions)   Q1 2017(1)
    As Reported   Novitex   Pro Forma
Net loss   ($15.7)   ($9.7)   ($25.4)
Taxes     2.0     (3.0)     (1.0)
Interest expense     26.2     12.1     38.3
Depreciation and amortization     21.3     9.7     31.0
EBITDA   $33.9   $9.1   $43.0
Optimization and restructuring expenses     4.3     1.5     5.9
Transaction related costs     5.1     4.9     10.0
Non-cash charges     0.1     -      0.1
New contract setup     -      1.1     1.1
Oversight and management Fees     2.1     0.5     2.6
Adjusted EBITDA   $45.5   $17.3   $62.7
             

(1) Net loss for the period is presented on the basis of the previous debt structure at the respective standalone companies. As of July 12th, 2017 the existing debt structures at respective Exela entities have been replaced with a new capital structure consisting of $350 million Term Loan and $1.0 Billion Senior Secured Notes.

Exela Technologies

Schedule 3: Adjusted EBITDA Reconciliation – Fourth Quarter 2017 vs. First Quarter 2018

             
  ($ in millions)   As Reported  
   

Q1 2018
 

Q4 2017
 
  Net loss     ($24.0 )     ($58.7 )  
  Taxes       4.0         (27.3 )  
  Interest expense       38.0         36.7    
  Depreciation and amortization       38.0         28.1    
  EBITDA     $56.1       ($21.1 )  
  Impairment of goodwill and other intangible assets       -          69.4    
  Optimization and restructuring expenses       14.5         11.0    
  Transaction related costs       1.1         2.4    
  Non-cash charges       1.3         2.3    
  (Gain) / loss on derivative instruments       (3.3 )       (1.3 )  
  Adjusted EBITDA     $69.6       $62.7    
             

Exela Technologies 

Schedule 4: SG&A (Including Related Party) – Pro Forma First Quarter 2017, Fourth Quarter 2017 and 

First Quarter 2018

                     
    As Reported   Q1 2017
($ in millions)   Q1 2018   Q4 2017   Pro Forma   As Reported   Novitex
                     
Selling, general and administrative expenses     45.6     48.3     51.6     35.6     16.0
Related party expense     1.1     1.7     2.7     2.4     0.3
Total   $46.7   $50.0   $54.3   $38.0   $16.3
                     

Exela Technologies 

Schedule 5: Pro Forma Reconciliation – First Quarter 2017

             
    Q1 2017(1)
($ in millions)   As Reported   Novitex   Pro Forma
Revenue   $218.3   $143.6   $361.9
Cost of revenue (exclusive of depreciation and amortization)   143.7   118.2   261.9
Selling, general and administrative expenses (Including related party)   38.0   16.3   54.3
Depreciation and amortization   21.3   9.7   31.0
Operating income (loss)   15.3   (0.6)   14.7
             
Interest expense, net   26.2   12.1   38.3
Sundry expense (income) & other income, net   2.7     -      2.7
Net loss before income taxes   (13.7)   (12.7)   (26.4)
Income tax (benefit) expense   2.0   (3.0)   (1.0)
Net loss   ($15.7)   ($9.7)   ($25.4)
             

(1) Net loss for the period is presented on the basis of the previous debt structure at the respective standalone companies. As of July 12th, 2017 the existing debt structures at respective Exela entities have been replaced with a new capital structure consisting of $350 million Term Loan and $1.0 Billion Senior Secured Notes.

Exela Technologies

Schedule 6: Pro forma capital expenditures – First Quarter 2017

             
($ in millions)   Q1 2017
  Acquirer   Novitex   Pro Forma
             
Capital expenditures     8.6     2.5     11.1
             
             

Exela Technologies 

Schedule 7: Further Adjusted EBITDA Calculation Pro Forma 2017

     
($ in millions)   Pro Forma
  FY 2017
Net Loss   ($242.4)
Taxes   (67.2)
Interest expense   153.4
Depreciation and amortization   119.5
Impairment of goodwill and other intangible assets   69.4
(Gain) / loss on extinguishment of debt   53.0
Optimization and restructuring expenses   47.9
Transaction related costs   99.0
Non-cash charges   6.7
New contract setup   2.0
Oversight and management Fees   5.1
(Gain) / loss on derivative instruments   (1.3)
Gain / (loss) on currency exchange   2.4
Combined merger adjustments   99.2
Further Adjusted EBITDA   $346.8
     

 

Contact: Jim Mathias

E: ir@exelatech.com

W: http://investors.exelatech.com

+1 972-821-5808